iPredict study for atrial heart muscle changes over time
Part of Heart & circulation clinical trials.
This study tracks how “atrial myopathy” (changes in the heart’s upper chambers) develops over time in people with atrial fibrillation or higher heart-risk. It uses special heart MRI pictures and regular follow-up to better predict progression, which may help future care planning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18–79 with atrial fibrillation, or 40–79 with higher heart disease risk
- You have internet or email at home
- You have a compatible smartphone or tablet (iPhone 4S or newer, or iPad 3 or newer, or compatible Android)
- You can read, understand, and sign consent forms
- You can return to the study clinic about 1 year later for repeat heart MRI
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at early changes in the heart related to atrial fibrillation (AF) using health data and biomarkers. It aims to find better ways to predict or understand AF, especially around procedures like ablation or cardioversion.
This trial checks whether a specific MRI-safe 12-lead heart recording (ECG) works correctly during MRI scans. It may help improve how doctors monitor heart rhythm while imaging, especially for people with atrial fibrillation.
This trial uses a smartphone and smartwatch to track your atrial fibrillation over time. It aims to understand how the condition progresses and the risk of blood clots.
This trial looks at how the heart's electrical signals work in people with hypertrophic cardiomyopathy (a condition where the heart muscle becomes thickened) who also have atrial fibrillation (a type of irregular heartbeat). The goal is to understand these signals better during a planned ablation procedure, which is a treatment to fix the irregular rhythm.
This study uses a smartwatch and a longer heart-monitoring test (a Holter) to find an irregular heart rhythm called atrial fibrillation after a stroke whose cause is unclear. If they detect it, it may help guide better prevention and treatment to reduce future stroke risk.
This trial uses a special long-term heart monitor (one wire) that uses artificial intelligence to find new cases of atrial fibrillation, a type of irregular heartbeat that can increase stroke risk. If you're 60 or older and haven't had AF before, this study could help catch it early.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.